β³ Fetching live dividend data...
Home βΊ Calculator βΊ SSMXF Dividend Calculator 2026
Sysmex Corporation Β· OTC
Price: $11.35 Β· Annual div: $0.2467/share Β· Frequency: semi-annual Β· Payout ratio: N/A Β· Ex-div: 2027-03-30
SSMXF (Sysmex Corporation) has a dividend yield of 2.17%, based on an annual dividend of $0.2467 per share and a price of $11.35. Over the last 12 months it paid $0.2467 per share β a trailing yield of 2.17%. Dividends are paid semi-annual.
Yield history: over the last 12 payments, SSMXF's 12-month yield ranged from 0.54% to 2.76%. Full SSMXF dividend history β
With dividends reinvested, a SSMXF position grows its share count by about 2.17% in the first year at today's price and yield.
| Year | Shares bought by dividends |
|---|
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2027-03-30Latest | 2027-03-30 | $0.1275 | β | β |
| 2026-09-30 | β | $0.1272 | 2.01% | $12.30 |
| 2026-03-31 | 2026-06-29 | $0.1195 | 2.76% | $8.97 |
| 2025-09-30 | 2025-12-02 | $0.1284 | 1.93% | $12.50 |
| 2025-03-31 | 2025-06-30 | $0.1134 | 1.17% | $18.60 |
| 2024-09-30 | 2024-12-03 | $0.1040 | 1.10% | $17.79 |
| 2024-03-28 | 2024-06-24 | $0.0925 | 1.48% | $19.65 |
| 2023-09-29 | 2023-12-04 | $0.0937 | 1.14% | $17.55 |
| 2023-03-30 | 2023-06-26 | $0.1055 | 1.00% | $19.79 |
| 2022-09-29 | 2022-12-05 | $0.0927 | 0.89% | $21.65 |
| 2022-03-30 | 2022-06-27 | $0.1003 | 0.83% | $25.46 |
| 2021-09-29 | 2021-12-06 | $0.1107 | 0.57% | $38.58 |
| 2021-03-30 | 2021-06-28 | $0.1093 | 0.54% | $41.25 |
| 2020-09-29 | 2020-12-01 | $0.1137 | β | β |
| 2020-03-30 | 2020-06-22 | $0.1113 | β | β |
| 2019-09-27 | 2019-12-02 | $0.1113 | β | β |
| 2019-03-27 | 2019-06-24 | $0.1083 | β | β |
| 2018-09-26 | 2018-12-03 | $0.1004 | β | β |
| 2018-03-28 | 2018-06-25 | $0.0950 | β | β |
| 2017-09-27 | 2017-12-04 | $0.0887 | β | β |
| 2017-03-29 | 2017-06-26 | $0.0840 | β | β |
| 2016-09-28 | 2016-12-05 | $28.0000 | β | β |
| 2016-03-29 | 2016-06-27 | $0.0587 | β | β |
| 2015-09-28 | 2015-12-02 | $0.0553 | β | β |
| 2015-03-27 | 2015-06-22 | $0.0447 | β | β |
| 2014-09-26 | 2014-12-02 | $0.0430 | β | β |
| 2014-03-27 | 2014-06-23 | $0.0343 | β | β |
| 2013-09-26 | 2013-12-02 | $10.5000 | β | β |
| 2013-03-27 | 2013-06-24 | $9.5000 | β | β |
| 2012-09-26 | 2012-12-03 | $8.5000 | β | β |
| 2012-03-28 | 2012-06-25 | $0.0383 | β | β |
| 2011-09-28 | 2011-12-02 | $7.5000 | β | β |
| 2011-03-29 | 2011-06-27 | $0.0324 | β | β |
| 2010-09-28 | 2010-12-03 | $0.0278 | β | β |
| 2010-03-29 | 2010-06-28 | $0.0279 | β | β |
| 2009-09-25 | 2009-12-04 | $0.0232 | β | β |
| 2009-03-26 | 2009-06-22 | $0.0219 | β | β |
| 2008-09-25 | 2008-12-05 | $0.0188 | β | β |
| 2008-03-26 | 2008-06-23 | $0.0236 | β | β |
| 2007-09-25 | 2007-12-07 | $0.0145 | β | β |
| 2007-03-27 | 2007-06-25 | $0.0141 | β | β |
| 2006-09-26 | 2006-12-08 | $0.0114 | β | β |
| 2006-03-28 | 2006-06-26 | $0.0114 | β | β |
| 2005-09-27 | 2005-12-09 | $0.0074 | β | β |
| 2005-03-28 | 2005-06-27 | $0.0097 | β | β |
| 2004-09-27 | 2004-12-10 | $0.0057 | β | β |
| 2004-03-26 | 2004-06-28 | $0.0071 | β | β |
| 2003-09-25 | 2003-12-10 | $0.0045 | β | β |
| 2003-03-26 | 2003-06-27 | $0.0049 | β | β |
| 2002-09-25 | 2002-12-10 | $0.0037 | β | β |
| 2002-03-26 | 2002-06-28 | $0.0034 | β | β |
| 2001-09-25 | 2001-12-10 | $0.0039 | β | β |
| 2001-03-27 | 2001-06-29 | $0.0041 | β | β |
| 2000-09-26 | 2000-12-08 | $0.0039 | β | β |
| 2000-03-28 | 2000-06-30 | $0.0047 | β | β |
| 1999-09-27 | 1999-12-10 | $0.4167 | β | β |
| 1999-03-26 | 1999-06-30 | $0.5000 | β | β |
Headquartered in Kobe, Japan, Sysmex Corporation is a global leader in the creation, production, and distribution of sophisticated diagnostic instruments, chemical reagents, and related software. Their extensive product portfolio addresses a wide array of laboratory needs. Within hematology, Sysmex provides advanced three-part and five-part white blood cell differentiation instruments, alongside efficient transport systems designed for high-throughput laboratory environments. Their offerings further encompass automated analyzers for both urine particles and blood coagulation. The company also specializes in automated immunochemistry systems, capable of performing intricate assays on minute sample volumes, complemented by reagents for detecting infectious diseases and tumor markers. Additionally, Sysmex manufactures essential flow cytometers utilized in diagnosing conditions such as leukemia, malignant lymphoma, and HIV/AIDS. Beyond these core diagnostic tools, Sysmex offers specialized systems for detecting cancer lymph node metastasis and provides comprehensive laboratory assay services. The company's operations extend into developing and commercializing software for diagnostic information systems, and delivering a range of services including facility management, administrative support, employee welfare, and genetic analysis. They are deeply involved in the conception, operation, and maintenance of IT solutions, platforms, and applications tailored for digital medicine. Sysmex also actively participates in the entire lifecycle of medical robots, from marketing and development to design, manufacturing, sales, and post-sales support. Furthermore, the company manages the distribution and after-sales support for medical devices and reagents used across biotechnology, medical technology, and molecular cell analysis. Sysmex is committed to research, development, manufacturing, and commercialization of regenerative medicine products and biodevices, while also developing, maintaining, and selling general computer software and offering blood DNA testing services. Sysmex serves a diverse international client base, including national and public hospitals, private healthcare facilities, universities, research institutions, and various other medical organizations. Their global reach is substantial, with product exports to approximately 190 countries. Founded in 1968, the company initially operated as TOA Medical Electronics Co., Ltd., adopting the name Sysmex Corporation in October 1998.
SSMXF (Sysmex Corporation) has a dividend yield of 2.17%, based on an annual dividend of $0.2467 per share and a price of $11.35. Over the last 12 months it paid $0.2467 per share β a trailing yield of 2.17%. Dividends are paid semi-annual.
$10,000 in SSMXF at a 2.17% yield pays about $217 a year ($18 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
With dividends reinvested, a SSMXF position grows its share count by about 2.17% in the first year at today's price and yield.
Enter your starting amount, monthly contribution and time horizon in the SSMXF DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
SSMXF's next ex-dividend date is 2027-03-30. SSMXF pays dividends semi-annual. Buy before the ex-dividend date to receive the next payment.
SSMXF's dividend changed 2.0% over the last year and -12.8% a year on average over five years.
Forward dividend yield from the latest data Β· open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open SSMXF position with:
Real after-tax yield depends on where you live and how you hold SSMXF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 2.17% | -0.63% | $217 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 1.84% | -0.96% | $184 / yr |
| πΊπΈ US Taxable (20%) | 20% | 1.74% | -1.06% | $174 / yr |
| π¬π§ UK ISA | 0% | 2.17% | -0.63% | $217 / yr |
| π¬π§ UK Taxable | 8.75% | 1.98% | -0.82% | $198 / yr |
| π¨π¦ TFSA | 0% | 2.17% | -0.63% | $217 / yr |
| π¨π¦ CA Taxable | 25% | 1.63% | -1.17% | $163 / yr |
| π¦πΊ Super (pension) | 15% | 1.84% | -0.96% | $184 / yr |
| π¦πΊ AU Taxable | 30% | 1.52% | -1.28% | $152 / yr |
| π©πͺ DE Taxable | 26.375% | 1.60% | -1.20% | $160 / yr |
| π«π· FR Taxable | 30% | 1.52% | -1.28% | $152 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.25/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
SSMXF pays quarterly β 4 times per year. Ex-div: 2027-03-30.
How SSMXF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SSMXF sourced from FMP /financial-growth endpoint β real data, not estimates.
Compare SSMXF with peers: SSMXF vs CNVVF Β· SSMXF vs CNVVY Β· SSMXF vs ESAIY
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SSMXF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Sysmex Corporation (SSMXF) is currently trading at $11.35, 9% below its 52-week high. The current dividend yield is 2.17% based on an annual payout of $0.2467 per share.
Sysmex Corporation (SSMXF) is a healthcare stock currently trading at $11.35 with a dividend yield of 2.17%. It pays an annual dividend of $0.2467 per share. Over the past 5 years, SSMXF's dividend has declined at an average rate of 12.8% a year.
Auto-generated from live market data. For educational purposes only β not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team β not customer reviews.
| Total shares |
|---|
| Dividend income |
|---|
| Position value |
|---|
| Yield on cost |
|---|
| 1 | 19.15 | 900.21 | $196 | $9,196 | 1.96% |
| 3 | 19.99 | 939.77 | $165 | $7,776 | 1.65% |
| 5 | 20.87 | 981.06 | $140 | $6,575 | 1.40% |
| 10 | 23.24 | 1092.42 | $92 | $4,323 | 0.92% |
| 20 | 28.81 | 1354.49 | $40 | $1,869 | 0.40% |
DRIP rate = share-count growth from reinvested dividends. Simplified yearly model before taxes and fees; adjust every assumption in the calculator above. Not financial advice. How DRIP and the DRIP rate work β
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever